| 英文名称 | 中文名称 | CAS | MF |
|
4,4-dimethylpyrrolidine-2-carboxylic acid hydrochloride
|
2197372-53-3
|
2197372-53-3
|
C7H14ClNO2
|
|
Lenalidomide Impurity 7
|
10MG, 25MG, 50MG, 100MG, OTHER SCALE PLEASE EMAIL SALES@PIPITECH.COM
|
2197414-55-2
|
C13H16N4O3
|
|
Formamide, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-
|
Formamide, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-4-yl]-
|
2197414-56-3
|
C14H13N3O4
|
|
2H-Isoindole-2-butanoic acid, 4-amino-γ-(aminocarbonyl)-1,3-dihydro-1-oxo-
|
来那度胺杂质56
|
2197414-57-4
|
C13H15N3O4
|
|
Hexahydro-2H-pyrazino[1,2-a]pyrazin-1(6H)-one dihydrochloride
|
Hexahydro-2H-pyrazino[1,2-a]pyrazin-1(6H)-one dihydrochloride
|
2197416-30-9
|
C7H15Cl2N3O
|
|
Lenalidomide Impurity 1
|
来那度胺杂质01
|
2197420-75-8
|
C13H15N3O4
|
|
methyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-3-carboxylate*
|
7-羟基-5-氧代-1,2,3,5-四氢中氮茚-3-甲酸甲酯
|
2197422-77-6
|
C10H11NO4
|
|
1,4-Piperidinedicarboxylic acid, 3,3-difluoro-, 1-(1,1-dimethylethyl) ester, (4S)-
|
1,4-Piperidinedicarboxylic acid, 3,3-difluoro-, 1-(1,1-dimethylethyl) ester, (4S)-
|
2197504-56-4
|
C11H17F2NO4
|
|
1-(3-BROMOPHENYL)-N-METHYLETHANAMINE HYDROCHLORIDE
|
1-(3-溴苯基)-N-甲基乙胺盐酸
|
2197556-55-9
|
C9H13BrClN
|
|
Ethyl 8-chloro-4H-thieno[3,2-c]thiochromene-2-carboxylate
|
Ethyl 8-chloro-4H-thieno[3,2-c]thiochromene-2-carboxylate
|
2197715-18-5
|
C14H11ClO2S2
|
|
Propanamide, 2-amino-3-[(triphenylmethyl)thio]-, (2S)-
|
(S)-2-氨基-3-(三苯甲基硫基)丙酰胺
|
2197916-89-3
|
C22H22N2OS
|
|
2,5-Bis-(2-ethyl-hexyl)-3-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-thiophen-2-yl]-6-thiophen-2-yl-2,5-dihydro-pyrrolo[3,4-c]pyrrole-1,4-dione
|
2,5-Bis-(2-ethyl-hexyl)-3-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-thiophen-2-yl]-6-thiophen-2-yl-2,5-dihydro-pyrrolo[3,4-c]pyrrole-1,4-dione
|
2197974-48-2
|
C36H51BN2O4S2
|
|
(T-4)-[4-[5-[[4-[4-(Diphenylamino)phenyl]-3,5-dimethyl-2H-pyrrol-2-ylidene-κN]phenylmethyl]-2,4-dimethyl-1H-pyrrol-3-yl-κN]-N,N-diphenylbenzenaminato]difluoroboron
|
2,8-双(4-(二苯基氨基)苯基)-5,5-二氟-1,3,7,9-四甲基-10-苯基-5H-二吡咯并[1,2-C:2',1'-F][1,3,2]二氮杂硼烷-4-鎓-5-硼
|
2197983-48-3
|
C55H45BF2N4
|
|
(R)-3-(trifluoromethyl)pyrrolidine hydrochloride
|
(R)-3-(三氟甲基)吡咯烷盐酸盐
|
2198055-96-6
|
C5H9ClF3N
|
|
2-Azaspiro[3.3]heptane-2-carboxylic acid, 5-amino-, 1,1-dimethylethyl ester, hydrochloride (1:1), (5R)-
|
|
2198056-37-8
|
C11H20N2O2.ClH
|
|
Oxetane, 2-(bromomethyl)-, (2S)-
|
Oxetane, 2-(bromomethyl)-, (2S)-
|
2198099-00-0
|
C4H7BrO
|
|
1,3-Pyrrolidinedicarboxylic acid, 3-methyl-, 1-(1,1-dimethylethyl) ester, (3R)-
|
(R)-1-((叔丁氧)羰基)-3-甲基吡咯烷-3-羧酸
|
2198242-27-0
|
C11H19NO4
|
|
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)-
|
(R)-3-(4-溴-1H-吡唑-1-基)吡咯烷-1-羧酸叔丁酯
|
2198312-46-6
|
C12H18BrN3O2
|
|
3-Pyridinecarbonitrile, 5-(aminomethyl)-, hydrochloride (1:1)
|
5-氨甲基烟腈盐酸盐
|
2198774-67-1
|
C7H8ClN3
|
|
N-(4-Chloro-2,5-dimethoxyphenyl)-N'-[2-methyl-3-(trifluoromethyl)phenyl]thiourea
|
N-(4-Chloro-2,5-dimethoxyphenyl)-N'-[2-methyl-3-(trifluoromethyl)phenyl]thiourea
|
2198846-62-5
|
C17H16ClF3N2O2S
|
|
(R)-3,3-Difluoro-cyclohexylamine hydrochloride
|
(R)-3,3-二氟环己胺盐酸盐
|
2199141-40-5
|
C6H12ClF2N
|
|
tert-butyl (3R)-3-amino-3-methyl-piperidine-1-carboxylate
|
tert-butyl (3R)-3-amino-3-methyl-piperidine-1-carboxylate
|
2199214-46-3
|
C11H22N2O2
|
|
(R)-tert-butyl 4-amino-3,3-difluoropyrrolidine-1-carboxylate
|
(R)-4-氨基-3,3-二氟吡咯烷-1-羧酸叔丁酯
|
2199214-47-4
|
C9H16F2N2O2
|
|
(R)-3-(1-aminoethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
|
(R)-3-(1-氨基乙基)-8-氯-2-苯基异-1(2H)-酮
|
2199389-46-1
|
C17H15ClN2O
|
|
3-iodo-N,N-dimethylpropan-1-amine hydrochloride
|
3-IODO-N,N-DIMETHYLPROPAN-1-AMINE HYDROCHLORIDE
|
2199436-61-6
|
C5H13ClIN
|
|
Benzeneacetic acid, 4-(2-chloroethyl)-α,α-dimethyl-
|
2-(4-(2-氯乙基)苯基)-2-甲基丙酸
|
2199440-16-7
|
C12H15ClO2
|
|
4-CYANO-2,6-DIFLUOROPHENYLBORONIC ACID
|
4-CYANO-2,6-DIFLUOROPHENYLBORONIC ACID
|
2199440-52-1
|
C7H4BF2NO2
|
|
Prionidipene A
|
Prionidipene A
|
2199455-72-4
|
C21H26O3
|
|
L-Glutamamide, N2-[[cis-4-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]cyclohexyl]carbonyl]-N-[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]-L-α-glutaminyl-N1,N5-bis[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]-
|
激肽释放酶抑制剂肽
|
2199491-27-3
|
C80H127N10O37P
|
|
(S)-3,3-Difluoro-cyclohexylamine hydrochloride
|
(S)-3,3-二氟环己胺盐酸盐
|
2199497-63-5
|
C6H12ClF2N
|
|
SHP099 (hydrochloride)
|
6- (4- 氨基- 4- 甲基- 1- 哌啶基) - 3- (2, 3- 二氯苯基) - 2- 吡嗪胺,盐酸盐(1:1 )
|
2200214-93-1
|
C16H20Cl3N5
|
|
2-bromo-4-chloro-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole
|
2-bromo-4-chloro-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-imidazole
|
2200238-98-6
|
C9H16BrClN2OSi
|
|
(S)-(5-Azaspiro[2.4]heptan-6-yl)methanol hydrochloride
|
(S)-(5-氮杂螺[2.4]庚烷-6-基)甲醇盐酸盐
|
2200258-97-3
|
C7H14ClNO
|
|
(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride
|
(αR)-α-Methyl-N-[3-[3-(trifluoromethyl)phenyl]propyl]-2-naphthalenemethanamine Hydrochloride
|
2200269-28-7
|
C22H23ClF3N
|
|
5-Bromo-4-chloro-3-indolyl b-D-lactopyranoside
|
5-Bromo-4-chloro-3-indolyl b-D-lactopyranoside
|
2200269-31-2
|
C20H25BrClNO11
|
|
(6S)-5-azaspiro[2.4]heptane-6-carboxylic acid hydrochloride
|
(6S)-5-azaspiro[2.4]heptane-6-carboxylic acid hydrochloride
|
2200278-74-4
|
C7H12ClNO2
|
|
2-(Methyl-d3)-phenylboronic acid
|
2-(甲基-D3)-苯基硼酸
|
2200293-21-4
|
C7H9BO2
|
|
1-Piperidinecarboxylic acid, 3-fluoro-4,4-dihydroxy-, 1,1-dimethylethyl ester, (3R)-
|
(R)-3-氟-4,4-二羟基哌啶-1-羧酸叔丁酯
|
2200580-26-1
|
C10H18FNO4
|
|
(S)-3-(piperidin-3-yl)benzoic acid hydrochloride
|
2200580-27-2
|
2200580-27-2
|
C12H16ClNO2
|
|
(2R)-oxetane-2-carboxylic acid
|
(R)-氧杂环丁烷-2-羧酸
|
2200583-25-9
|
C4H6O3
|
|
Imidazo[1,2-a]pyrazine, 8-[(2-fluorophenyl)methyl]-6-[5-(trifluoromethyl)-1H-1,2,4-triazol-3-yl]-
|
ZAGOCIGUAT
|
2201048-82-8
|
C16H10F4N6
|
|
Imidazo[1,2-a]pyrazine, 6-bromo-8-[(3-fluorophenyl)methyl]-
|
6-溴-8-(3-氟苄基)咪唑并[1,2-A]吡嗪
|
2201049-54-7
|
C13H9BrFN3
|
|
5-chloro-3-(cyclohex-1-en-1-yl)-7-methoxy-6-(4-methoxyphenyl)-2-phenylpyrazolo[1,5-a]pyrimidine
|
5-氯-3-(1-环己烯-1-基)-7-甲氧基-6-(4-甲氧基苯基)-2-苯基吡唑[1,5-A]嘧啶
|
2201056-62-2
|
C26H24ClN3O2
|
|
Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)-
|
Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-6-(4-methoxyphenyl)-2-phenyl-5-(2-pyridinylamino)-
|
2201056-66-6
|
C30H27N5O2
|
|
MAT2A inhibitor
|
MAT2A inhibitor
|
2201057-10-3
|
C31H22N6OS
|
|
4-(CYCLOHEX-1-EN-1-YL)-3-PHENYL-1H-PYRAZOL-5-AMINE
|
4-(CYCLOHEX-1-EN-1-YL)-3-PHENYL-1H-PYRAZOL-5-AMINE
|
2201057-79-4
|
C15H17N3
|
|
Pyrazolo[1,5-a]pyrimidin-7(4H)-one, 3-(1-cyclohexen-1-yl)-5-hydroxy-6-(4-methoxyphenyl)-2-phenyl-
|
3-(1-环己烯-1-基)-6-(4-甲氧基苯基)-2-苯基-5-羟基吡唑[1,5-A]嘧啶-7(4H)-酮
|
2201057-80-7
|
C25H23N3O3
|
|
5,7-dichloro-3-(cyclohex-1-en-1-yl)-6-(4-methoxyphenyl)-2-phenylpyrazolo[1,5-a]pyrimidine
|
5,7-二氯-3-(1-环己烯-1-基)-6-(4-甲氧基苯基)-2-苯基吡唑[1,5-A]嘧啶
|
2201057-82-9
|
C25H21Cl2N3O
|
|
Pyrazolo[1,5-a]pyrimidin-5-amine, 3-(1-cyclohexen-1-yl)-7-methoxy-6-(4-methoxyphenyl)-2-phenyl-N-2-pyridinyl-
|
3-(1-环己烯-1-基)-7-甲氧基-6-(4-甲氧基苯基)-2-苯基-N-2-吡啶基吡唑[1,5-A]嘧啶-5-胺
|
2201057-92-1
|
C31H29N5O2
|
|
1H-Pyrazol-5-amine, 1-[(4-methoxyphenyl)methyl]-3-phenyl-
|
1-(4-甲氧基苄基)-3-苯基-1H-吡唑-5-胺
|
2201058-76-4
|
C17H17N3O
|
|
4-(cyclohex-1-en-1-yl)-1-(4-methoxybenzyl)-3-phenyl-1H-pyrazol-5-amine
|
4-(环己-1-烯-1-基)-1-(4-甲氧基苄基)-3-苯基-1H-吡唑-5-胺
|
2201058-77-5
|
C23H25N3O
|
|
1H-Pyrazole-1-propanamide, 4-bromo-β-cyclopentyl-, (βR)-
|
(R)-3-(4-溴-1H-吡唑-1-基)-3-环戊基丙烷酰胺
|
2201066-06-8
|
C11H16BrN3O
|
|
2,3-diphenyl-6-(quinolin-6-yl)pyrazolo[1,5-a]pyrimidin-7(4H)-one
|
化合物 T10259
|
2201066-35-3
|
C27H18N4O
|
|
AGI-24512
|
AGI-24512
|
2201066-53-5
|
C24H24N4O2
|
|
Benzoic acid, 2-chloro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester
|
2-氯-3-(4,4,5,5-四甲基-1,3,2-二氧硼烷-2-基)苯甲酸甲酯
|
2201133-24-4
|
C14H18BClO4
|
|
4-(Bromomethyl)-3-methylpyridine hydrobromide
|
4-(溴甲基)-3-甲基吡啶氢溴酸盐
|
2201551-69-9
|
C7H9Br2N
|
|
Carbamic acid, N-(3-acetylbicyclo[1.1.1]pent-1-yl)-, 1,1-dimethylethyl ester
|
Carbamic acid, N-(3-acetylbicyclo[1.1.1]pent-1-yl)-, 1,1-dimethylethyl ester
|
2201551-76-8
|
C12H19NO3
|
|
N-(2,4-Dibromo-6-fluorophenyl)azepane-1-carbothioamide
|
N-(2,4-Dibromo-6-fluorophenyl)azepane-1-carbothioamide
|
2201551-82-6
|
C13H15Br2FN2S
|
|
tert-butyl (R)-2,7-diazaspiro[4.4]nonane-2-carboxylate
|
(R)-2,7-二氮杂螺[4.4]壬烷-2-羧酸叔丁酯
|
2201785-36-4
|
C12H22N2O2
|
|
2(1H)-Pyridinone, 4-(2-acetyl-5-chlorophenyl)-5-methoxy-
|
2(1H)-Pyridinone, 4-(2-acetyl-5-chlorophenyl)-5-methoxy-
|
2201839-83-8
|
C14H12ClNO3
|
|
Apremilast Impurity 19
|
阿普斯特杂质19
|
2201974-01-6
|
C22H24N2O7S
|
|
tert-butyl (R)-((3-fluoropiperidin-3-yl)methyl)carbamate
|
(R)-((3-氟哌啶-3-基)甲基)氨基甲酸叔丁酯
|
2202263-12-3
|
C11H21FN2O2
|
|
4,18-Dihydro-4-hydroxysaprirearine
|
4,18-Dihydro-4-hydroxysaprirearine
|
2202760-88-9
|
C20H26O3
|
|
(R)-(tetrahydro-2H-pyran-2-yl)methanamine hydrochloride
|
(R)-(四氢-2H-吡喃-2-基)甲胺盐酸盐
|
2202897-24-1
|
C6H14ClNO
|
|
1-(3-Chloro-5-fluorophenyl)ethanamine hydrochloride
|
1-(3-Chloro-5-fluorophenyl)ethanamine hydrochloride
|
2203194-97-0
|
C8H10Cl2FN
|
|
3-Pyrrolidinemethanol, α,α-dimethyl-, hydrochloride (1:1), (3R)-
|
(R)-2-(吡咯烷-3-基)丙-2-醇盐酸盐
|
2203403-97-6
|
C7H16ClNO
|
|
6,7-dihydropyrrolo[3,4-b]pyrazin-5-one
|
6,7-dihydropyrrolo[3,4-b]pyrazin-5-one
|
2203486-14-8
|
C6H5N3O
|
|
Hydroxy O-Desmethyl Apixaban Sulfate
|
Hydroxy O-Desmethyl Apixaban Sulfate
|
2203515-00-6
|
C24H23N5O8S
|
|
Alprazolam EP Impurity H
|
Alprazolam EP Impurity H
|
2203515-05-1
|
C17H13ClN4
|
|
Alogliptin Impurity 16
|
阿格列汀杂质16
|
2203540-91-2
|
C13H10ClN3O2
|
|
4H-Indol-4-one, 3-(4-fluorophenyl)-1,5,6,7-tetrahydro-1-methyl-
|
3-(4-氟苯基)-1-甲基-6,7-二氢-1H-吲哚-4(5H)-酮
|
2203540-92-3
|
C15H14FNO
|
|
Apixaban Impurity 16
|
阿哌沙班杂质19
|
2203740-09-2
|
C26H29N5O5
|
|
8-Methoxy Entecavir
|
8-甲氧基恩替卡韦
|
2203740-23-0
|
C13H17N5O4
|
|
2-oxabicyclo[3.2.0]heptan-7-amine hydrochloride
|
2203940-24-1
|
2203940-24-1
|
C6H12ClNO
|
|
4-IODO-3-METHOXY-1-METHYL-1H-PYRAZOLE
|
4-碘-3-甲氧基-1-甲基-1H-吡唑
|
2203986-20-1
|
C5H7IN2O
|
|
(3-methyl-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)methanol*
|
(3-甲基-1-(四氢-2H-吡喃-2-基)-1H-吡唑-5-基)甲醇
|
2204091-98-3
|
C10H16N2O2
|
|
tert-butyl4-((2-bromo-4-fluorophenyl)amino)-4-cyanopiperidine-1-carboxylate*
|
叔-丁基 4-((2-溴-4-氟苯基)氨基)-4-氰基哌啶-1-甲酸基酯
|
2204141-39-7
|
C17H21BrFN3O2
|
|
Thalidomide-linker 13
|
Thalidomide-linker 13
|
2204226-02-6
|
C19H23ClN4O7
|
|
VX-659
|
2204245-48-5
|
2204245-48-5
|
C28H32F3N5O4S
|
|
5,8,11-Trioxa-2-azatridecanoic acid, 13-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]-, 1,1-dimethylethyl ester
|
(2-(2-(2-(2-((2-(2,6-二氧代哌啶-3-基)-1,3-二氧代异吲哚-4-基)氨基)乙氧基)乙氧基)乙氧基)乙基叔丁基)氨基甲酸酯
|
2204246-03-5
|
C26H36N4O9
|
|
(E)-4,4'-(1,2-diphenylethene-1,2-diyl)dibenzoic acid
|
(E)-4,4'-(1,2-diphenylethene-1,2-diyl)dibenzoic acid
|
2204249-15-8
|
C28H20O4
|
|
(1H-Pyrrolo[2,3-c]pyridin-2-yl)methanamine hydrochloride
|
(1H-吡咯并[2,3-C]吡啶-2-基)甲胺盐酸盐
|
2204255-39-8
|
C8H10ClN3
|
|
1-Propanesulfonamide, N-[cis-3-[methyl[7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]cyclobutyl]-
|
1-Propanesulfonamide, N-[cis-3-[methyl[7-[(4-methylphenyl)sulfonyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]cyclobutyl]-
|
2204275-76-1
|
C21H27N5O4S2
|
|
Fzd4 agonist FzM1.8)
|
Fzd4 agonist FzM1.8)
|
2204290-85-5
|
C18H14N2O4
|
|
Carbamic acid, N-[cis-3-(methylamino)cyclobutyl]-, phenylmethyl ester, hydrochloride (1:1)
|
((1S,3S)-3-(甲基氨基)环丁基)氨基甲酸苄酯盐酸盐
|
2204290-99-1
|
C13H19ClN2O2
|
|
Mal-PEG4-Glu(OH)-NH-m-PEG24
|
Mal-PEG4-Glu(OH)-NH-m-PEG24
|
2204309-09-9
|
C72H134N4O35
|
|
Apixaban Impurity 17
|
Apixaban Impurity 17
|
2204368-51-2
|
C29H31N5O5
|
|
(S)-5-chloro-N-(3-(5-chlorothiophene-2-carboxamido)-2- hydroxypropyl)-N-(4-(3-oxomorpholino)phenyl)thiophene-2- carboxamide
|
利伐沙班杂质12
|
2204368-63-6
|
C23H21Cl2N3O5S2
|
|
Palbociclib Impurity 9
|
帕布昔利布杂质9
|
2204368-66-9
|
C24H29N7O2
|
|
Quetiapine EP Impurity V
|
喹硫平EP杂质V
|
2204369-14-0
|
C21H25N3O2
|
|
Entecavir Impurity 17(Entecavir EP Impurity C)
|
8-羟基恩替卡韦
|
2204369-23-1
|
C12H15N5O4
|
|
Palbociclib Impurity 7
|
Palbociclib Impurity 7
|
2204442-50-0
|
C24H29N7O2
|
|
Sorafenib Impurity 6
|
Sorafenib Impurity 6
|
2204442-52-2
|
C27H23N5O6
|
|
3H-1,2,4-Triazol-3-one, 5-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4'-fluoro[1,1'-biphenyl]-4-yl)-4-morpholinyl]methyl]-1,2-dihydro-, rel-
|
3H-1,2,4-Triazol-3-one, 5-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4'-fluoro[1,1'-biphenyl]-4-yl)-4-morpholinyl]methyl]-1,2-dihydro-, rel-
|
2204442-75-9
|
C29H25F7N4O3
|
|
Losartan Butyl Ether
|
氯沙坦丁基醚
|
2204442-78-2
|
C26H31ClN6O
|
|
7(4H)-Benzothiazolone, 2-amino-5,6-dihydro-6-(propylamino)-, (6S)-
|
普拉克索杂质40
|
2204518-89-6
|
C10H15N3OS
|
|
Erlotinib Impurity 1
|
Erlotinib Impurity 1
|
2204518-92-1
|
C22H24ClN3O4
|
|
1-(2-Bromo-4-trifluoromethylphenyl)-ethylamine hydrochloride
|
苯甲胺,2-溴-Α-甲基-4-(三氟甲基)-,盐酸盐(1:1)
|
2204562-89-8
|
C9H10BrClF3N
|
|
8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one
|
帕博西尼杂质G
|
2204863-06-7
|
C24H29N7O
|
|
Methanone, [4-(1,1-dimethylethyl)-1-piperidinyl][4-(hydroxydiphenylmethyl)-2H-1,2,3-triazol-2-yl]-
|
化合物ML-211
|
2205032-89-7
|
C25H30N4O2
|